Lessons Learned from the Transgenic Huntington's Disease Rats

作者: Rinske Vlamings , Dagmar H Zeef , Marcus LF Janssen , Mayke Oosterloo , Frederic Schaper

DOI: 10.1155/2012/682712

关键词: NeuroscienceHuntington's diseaseHuntingtinPhenotypeRat modelBioinformaticsNeurodegenerationDiseaseTransgeneBiologyHuntingtin Protein

摘要: Huntington's disease (HD) is a fatal inherited disorder leading to selective neurodegeneration and neuropsychiatric symptoms. Currently, there no treatment slow down or stop the disease. There also therapy effectively reduce In investigation of novel therapies, different animal models disease, varying from insects nonhuman primates, have been created used. Few years ago, first transgenic rat model HD, carrying truncated huntingtin cDNA fragment with 51 CAG repeats under control native promoter, was introduced. We using this in our research review here experience behavioural, neurophysiological, histopathological phenotype rats relevant literature.

参考文章(71)
S. Hohn, G. Dallerac, A. Faure, Y. K. Urbach, H. P. Nguyen, O. Riess, S. von Horsten, P. Le Blanc, N. Desvignes, N. El Massioui, B. L. Brown, V. Doyere, Behavioral and In Vivo Electrophysiological Evidence for Presymptomatic Alteration of Prefrontostriatal Processing in the Transgenic Rat Model for Huntington Disease The Journal of Neuroscience. ,vol. 31, pp. 8986- 8997 ,(2011) , 10.1523/JNEUROSCI.1238-11.2011
Susan E. Andrew, Y. Paul Goldberg, Berry Kremer, Håkan Telenius, Jane Theilmann, Shelin Adam, Elizabeth Starr, Ferdinando Squitieri, Biaoyang Lin, Michael A. Kalchman, Rona K. Graham, Michael R. Hayden, The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease Nature Genetics. ,vol. 4, pp. 398- 403 ,(1993) , 10.1038/NG0893-398
Ali Jahanshahi, Rinske Vlamings, Ahmet Hilmi Kaya, Lee Wei Lim, Marcus L.F. Janssen, Sonny Tan, Veerle Visser-Vandewalle, Harry W.M. Steinbusch, Yasin Temel, Hyperdopaminergic status in experimental Huntington disease. Journal of Neuropathology and Experimental Neurology. ,vol. 69, pp. 910- 917 ,(2010) , 10.1097/NEN.0B013E3181EE005D
D. A. Simmons, C. S. Rex, L. Palmer, V. Pandyarajan, V. Fedulov, C. M. Gall, G. Lynch, Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 4906- 4911 ,(2009) , 10.1073/PNAS.0811228106
Gesine Paul, Wassilios Meissner, Susanne Rein, Daniel Harnack, Christine Winter, Kai Hosmann, Rudolf Morgenstern, Andreas Kupsch, Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease Experimental Neurology. ,vol. 185, pp. 272- 280 ,(2004) , 10.1016/S0014-4886(03)00363-7
Raphael M Bonelli, Peter Hofmann, A systematic review of the treatment studies in Huntington’s disease since 1990 Expert Opinion on Pharmacotherapy. ,vol. 8, pp. 141- 153 ,(2007) , 10.1517/14656566.8.2.141
Abdelhamid Benazzouz, Christian Gross, Jean Féger, Thomas Boraud, Bernard Bioulac, Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated Monkeys European Journal of Neuroscience. ,vol. 5, pp. 382- 389 ,(1993) , 10.1111/J.1460-9568.1993.TB00505.X
A. Giralt, T. Rodrigo, E.D. Martín, J.R. Gonzalez, M. Milà, V. Ceña, M. Dierssen, J.M. Canals, J. Alberch, Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: Involvement of phospholipaseCγ activity and glutamate receptor expression Neuroscience. ,vol. 158, pp. 1234- 1250 ,(2009) , 10.1016/J.NEUROSCIENCE.2008.11.024
Nanda Reedeker, Rose C. Van Der Mast, Erik J. Giltay, Erik Van Duijn, Raymond A.C. Roos, Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning. Movement Disorders. ,vol. 25, pp. 1612- 1618 ,(2010) , 10.1002/MDS.23136